IRIS
MANNI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.506
AS - Asia 726
EU - Europa 588
SA - Sud America 143
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.040
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.468
SG - Singapore 310
CN - Cina 137
IT - Italia 125
RU - Federazione Russa 117
BR - Brasile 113
HK - Hong Kong 83
SE - Svezia 77
VN - Vietnam 76
DE - Germania 58
GB - Regno Unito 54
FR - Francia 43
CI - Costa d'Avorio 40
FI - Finlandia 33
CA - Canada 22
IN - India 22
BD - Bangladesh 19
ID - Indonesia 16
BE - Belgio 14
ZA - Sudafrica 14
JP - Giappone 12
MX - Messico 12
NL - Olanda 12
IQ - Iraq 11
AR - Argentina 10
ES - Italia 10
PL - Polonia 10
TR - Turchia 10
UA - Ucraina 8
LT - Lituania 7
CO - Colombia 6
TN - Tunisia 6
PK - Pakistan 5
EC - Ecuador 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
HU - Ungheria 3
JO - Giordania 3
KE - Kenya 3
OM - Oman 3
PH - Filippine 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
LK - Sri Lanka 2
PE - Perù 2
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
UY - Uruguay 1
Totale 3.040
Salva come PNG Salva come JPEG
Città #
Ashburn 221
Singapore 185
Fairfield 145
San Jose 121
Chandler 115
Woodbridge 109
Hong Kong 83
Nyköping 61
Houston 58
Seattle 58
Beijing 54
Cambridge 46
Abidjan 40
Los Angeles 31
Wilmington 30
Ann Arbor 29
Helsinki 27
Ho Chi Minh City 25
Council Bluffs 24
Munich 23
Lauterbourg 21
New York 21
Bari 19
Brooklyn 16
Lawrence 16
Dallas 15
Moscow 15
Roxbury 15
São Paulo 15
Brussels 14
London 14
Toronto 14
Frankfurt am Main 13
Jakarta 13
Nuremberg 11
Santa Clara 11
Tokyo 11
Chicago 10
Des Moines 10
Jacksonville 10
Warsaw 10
Amsterdam 9
Hanoi 9
Johannesburg 9
Orem 9
Phoenix 9
Poplar 9
Atlanta 8
Bisceglie 8
Cagliari 8
Denver 8
Inglewood 8
Falkenstein 7
Princeton 7
Rome 7
Baghdad 6
Dong Ket 6
Montreal 6
Paris 6
Shenyang 6
Chennai 5
Fano 5
Gravina in Puglia 5
Milan 5
Nanjing 5
Rio de Janeiro 5
Shanghai 5
Ankara 4
Boardman 4
Buffalo 4
Da Nang 4
Dhaka 4
Guangzhou 4
Manchester 4
Mexico City 4
New Delhi 4
North Bergen 4
Norwalk 4
San Diego 4
San Francisco 4
Amman 3
Belo Horizonte 3
Boston 3
Brasília 3
Columbus 3
Dearborn 3
Grottaglie 3
Haiphong 3
Lviv 3
Miami 3
Muscat 3
Nairobi 3
Querétaro 3
Redwood City 3
Stockholm 3
The Dalles 3
Thái Bình 3
Tirana 3
Tunis 3
Valguarnera Caropepe 3
Totale 2.071
Salva come PNG Salva come JPEG
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 192
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 179
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 177
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register 166
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 159
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 158
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 155
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 128
Multiple Sclerosis Progression and Relapse Activity in Children 123
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis 116
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 115
Durvalumab and multiple sclerosis: a causal link or simple unmasking? 114
Magnetoencephalography and high‐density electroencephalography study of acoustic event related potentials in early stage of multiple sclerosis: A pilot study on cognitive impairment and fatigue 114
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method 110
Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group 109
Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy 108
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 105
Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study 101
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 100
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients 94
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review 93
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study 92
Dancing With Parkinson's Disease: The SI-ROBOTICS Study Protocol 81
Risk of Getting COVID-19 in People With Multiple Sclerosis 70
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 68
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments 60
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 28
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006) 24
Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients 20
Totale 3.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 21 19 17
2021/2022149 13 4 2 5 8 20 5 9 10 12 27 34
2022/2023276 36 46 18 19 33 30 9 34 33 1 8 9
2023/2024110 18 17 5 15 14 15 3 6 0 7 0 10
2024/2025615 36 4 46 31 31 55 94 66 11 29 66 146
2025/20261.361 213 58 104 158 200 90 138 50 195 155 0 0
Totale 3.159